PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

Dades bibliogràfiques
Autors principals:	Heynen, G, Kanis, J, Earnshaw, M, Woods, C, Oliver, D, Ledingham, J, Walton, R, Russell, R
Format:	Journal article
Publicat:	1976

Ítems similars

EVIDENCE THAT ENDOGENOUS CALCITONIN PROTECTS AGAINST RENAL BONE-DISEASE
per: Heynen, G, et al.
Publicat: (1976)

CALCITONIN, BONE-DISEASE, AND CHRONIC RENAL-FAILURE
per: Cundy, T, et al.
Publicat: (1978)

The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
per: Kanis, J, et al.
Publicat: (1977)

CALCITONINS ROLE - REPLY
per: Kanis, J, et al.
Publicat: (1977)

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
per: Kanis, J, et al.
Publicat: (1977)

Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease.
per: Kanis, J, et al.
Publicat: (1977)

Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
per: Kanis, J, et al.
Publicat: (1977)

VITAMIN-DS, MINERALS AND RENAL BONE-DISEASE
per: Kanis, J, et al.
Publicat: (1979)

Osteomalacia in renal disease.
per: Kanis, J, et al.
Publicat: (1980)

Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
per: Kanis, J, et al.
Publicat: (1979)

APPOSITIONAL RATES IN BONE IN PATIENTS WITH CHRONIC RENAL-DISEASE
per: Earnshaw, M, et al.
Publicat: (1979)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
per: Walton, R, et al.
Publicat: (1975)

Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
per: Kanis, J, et al.
Publicat: (1977)

Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption.
per: Henderson, R, et al.
Publicat: (1979)

Histological measurements in Paget's disease of bone.
per: Walton, R, et al.
Publicat: (1977)

VITAMIN-D IN CHRONIC RENAL-FAILURE
per: Kanis, J, et al.
Publicat: (1979)

THERAPEUTIC ADVANTAGE OF 1-ALPHA-HYDROXYLATED COMPOUNDS OVER VITAMIN-D
per: Kanis, J, et al.
Publicat: (1977)

Dialyzer Reuse Impact on Dialyzer Efficiency, Patient Morbidity and Mortality and Cost Effectiveness
per: Mitwalli Ahmed, et al.
Publicat: (2001-01-01)

THE PATHO-PHYSIOLOGY OF HYPERCALCEMIA
per: Kanis, J, et al.
Publicat: (1980)

Resistance of dialyzed patients to erythropoietin
per: Michelle Teodoro Alves, et al.
Publicat: (2015-06-01)

Diffusion in Tube Dialyzer
per: Yohannes Nigatie
Publicat: (2017-09-01)

Assessment of dialyzer surface in online hemodiafiltration; objective choice of dialyzer surface area
per: Francisco Maduell, et al.
Publicat: (2015-05-01)

Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
per: Hadeel M. Hameed, et al.
Publicat: (2025-01-01)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
per: Russell, R, et al.
Publicat: (1979)

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
per: Henderson, R, et al.
Publicat: (1974)

Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children
per: Esra Baskin, et al.
Publicat: (2004-01-01)

Sleep disorders in chronically dialyzed patients
per: Agnieszka Pluta, et al.
Publicat: (2018-10-01)

Sleep disorders in chronically dialyzed patients
per: Agnieszka Pluta, et al.
Publicat: (2018-10-01)

Carboxypeptidase B1 in dialyzed chronic kidney disease patients
per: Matej Stančík, et al.
Publicat: (2025-02-01)

Efficacy of Calcitonin on Bone Healing in Guinea Pigs
per: MA Erfani, et al.
Publicat: (2006-07-01)

Hemodynamic effects of succinate-containing dialyzing solution
per: A V Smirnov, et al.
Publicat: (2015-06-01)

The importance of psychological support for end-stage renal disease dialyzed patients
per: M. Regaya, et al.
Publicat: (2021-04-01)

NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.
per: Simona Granata, et al.
Publicat: (2015-01-01)

Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease
per: Andressa Louzada Frauche Fernandes, et al.

Potential study of regenerating waste dialyzer
per: Maryani, Basri
Publicat: (2014)

Regeneration and recycling hemodialysis membrane dialyzer
per: Siti Norsita, Mohd Rawi
Publicat: (2013)

Dialyzer reuse; effect on efficiency and biocompatibility
per: Atef H Huzayin, et al.
Publicat: (1999-01-01)

Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
per: Jingbo Xie, et al.
Publicat: (2020-01-01)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
per: Marcelo Bragança dos Reis Oliveira, et al.
Publicat: (2018-10-01)

Calcitonin in osteogenesis imperfecta.
per: Smith, R, et al.
Publicat: (1973)